These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12381908)

  • 1. Follow-up with serum Cyfra 21-1 in patients with squamous cell carcinomas of the head and neck.
    Kuropkat C; Lippert BM; Werner JA
    Oncology; 2002; 63(3):280-5. PubMed ID: 12381908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyfra 21-1: a serological help for detection of distant metastases in head and neck cancer.
    Maass JD; Hoffmann-Fazel A; Goeroegh T; Hoffmann M; Meyer JE; Gottschlich S; Rudert H; Maune S
    Anticancer Res; 2000; 20(3B):2241-3. PubMed ID: 10928185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYFRA 21-1: a suitable tumor marker in patients with head and neck cutaneous squamous cell carcinoma?
    Rudhart SA; Schultz JD; Gehrt F; Pavel FL; Birk R; Hoch M; Stuck BA; Hoch S
    Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3467-3475. PubMed ID: 31482332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cut-off value determination of CYFRA 21-1 for squamous cell carcinomas of the head and neck (SCCHN).
    Niemann AM; Goeroegh T; Gottschlich S; Lippert BM; Werner JA
    Anticancer Res; 1997; 17(4B):2859-60. PubMed ID: 9329547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Cyfra 21-1 and SCC assays in head and neck tumours.
    Banal A; Hacene K; Berthelot-Ruff E; Mahé E; Fontana X; Pichon MF
    Tumour Biol; 2001; 22(1):27-35. PubMed ID: 11054024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of a panel of tumor markers as prognostic factors in patients with squamous cell carcinoma of head and neck.
    Kandiloros D; Eleftheriadou A; Chalastras T; Kyriou L; Yiotakis I; Ferekidis E
    Med Oncol; 2006; 23(4):463-70. PubMed ID: 17303904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
    Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
    Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of a new tumour marker, CYFRA 21-1, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen.
    Yen TC; Lin WY; Kao CH; Cheng KY; Wang SJ
    Clin Otolaryngol Allied Sci; 1998 Feb; 23(1):82-6. PubMed ID: 9563673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of the usefulness of CYFRA 21-1 as a tumor marker in squamous cell carcinomas of the head and neck].
    Sano K; Kataoka S; Katoh T; Kawauchi H; Morikawa S
    Nihon Jibiinkoka Gakkai Kaiho; 1997 Jul; 100(7):790-7. PubMed ID: 9277101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma.
    Hsu YP; Hsieh CH; Chien HT; Lai CH; Tsao CK; Liao CT; Kang CJ; Wang HM; Chang JT; Huang SF
    World J Surg Oncol; 2015 Aug; 13():253. PubMed ID: 26292957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYFRA 21-1 in the early diagnosis of recurrent disease in non small cell lung carcinomas (NSCLC).
    Stieber P; Zimmermann A; Reinmiedl J; Müller C; Hoffmann H; Dienemann H
    Anticancer Res; 1999; 19(4A):2665-8. PubMed ID: 10470216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyfra 21-1 in diagnosis of distant metastases of head and neck carcinoma.
    Hoffmann-Fazel A; Hoffmann M; Gottschlich S; Maass JD; Rudert H; Maune S
    Anticancer Res; 2003; 23(2A):917-20. PubMed ID: 12820323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyfra 21-1 as a tumor marker for follow-up of patients with squamous cell carcinoma of the oropharynx.
    Alkotyfan K; Wiegand S; Müller HH; Windfuhr JP; Werner JA; Sesterhenn AM
    Anticancer Res; 2010 Jun; 30(6):2291-6. PubMed ID: 20651382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of cyfra 21-1, a tumor marker, in head and neck squamous cell carcinoma.
    Céruse P; Rabilloud M; Charrié A; Dubreuil C; Disant F
    Ann Otol Rhinol Laryngol; 2005 Oct; 114(10):768-76. PubMed ID: 16285267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CEA and Cyfra 21.1 study pre-treatment in 252 patients with head and neck carcinomas].
    Costey M; Mora J; León X; López M; Orús C; Vergés J; Gañán L; Quer M
    Acta Otorrinolaringol Esp; 2004; 55(7):338-42. PubMed ID: 15554590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer.
    Wollenberg B; Jan V; Schmit UM; Hofmann K; Stieber P; Fateh-Moghadam A
    Anticancer Res; 1996; 16(5B):3117-24. PubMed ID: 8920778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
    Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of the tumour marker Cyfra 21-1 in carcinoma of head and neck and its role in early detection of recurrent disease.
    Doweck I; Barak M; Uri N; Greenberg E
    Br J Cancer; 2000 Dec; 83(12):1696-701. PubMed ID: 11104568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of therapy in head and neck patients during the radiotherapy by measurement of Cyfra 21-1.
    Pradier O; Hille A; Schmiberger H; Hess CF
    Cancer Radiother; 2002 Feb; 6(1):15-21. PubMed ID: 11899676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.